CorMedix (CRMD) Gross Margin Growth (5y) (2018 - 2025)

CorMedix (CRMD) Gross Margin Growth (5y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8,616.00
Sep 30, 2025 7,517.00
Jun 30, 2025 11,198.00
Mar 31, 2025 6,143.00
Dec 31, 2024 18,239.00
Sep 30, 2024 12,676.00
Jun 30, 2024 -334.00
Dec 31, 2022 -6,979.00
Sep 30, 2022 8,758.00
Jun 30, 2022 1,170.00
Mar 31, 2022 21,654.00
Dec 31, 2021 -1,488.00
Sep 30, 2021 3,274.00
Jun 30, 2021 95,762.00
Mar 31, 2021 5,175.00
Dec 31, 2020 61,032.00
Sep 30, 2020 1,131.00
Jun 30, 2020 -3,167.00
Mar 31, 2020 -1,068.00
Dec 31, 2019 13,613.00